Virtual Evolution of HVEM Segment for Checkpoint Inhibitor Discovery

Immune therapy has emerged as an effective treatment against cancers. Inspired by the PD-1/PD-L1 antibodies, which have achieved great success in clinical, other immune checkpoint proteins have drawn increasing attention in cancer research. B and T lymphocyte attenuator (BTLA) and herpes virus entry...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Mingjia, Zhao, Huimin, Miao, Yuhui, Luo, Shi-Zhong, Xue, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234244/
https://www.ncbi.nlm.nih.gov/pubmed/34205742
http://dx.doi.org/10.3390/ijms22126638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234244/
https://www.ncbi.nlm.nih.gov/pubmed/34205742
http://dx.doi.org/10.3390/ijms22126638

Ejemplares similares